Figure 3

Histopathological features of TC-PD-L1 expression and CD8+TIL density in pre-(C)RT and recurrence tissues (A), and clinical images (Patient 1:MRI and Patient 2: CT) from the pre-and post-nivolumab therapy patients (B) are shown for patients 1 and 2, respectively.